2012
DOI: 10.1007/s00408-012-9406-8
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Smoking and Gender on Pulmonary Function and Clinical Features in Sarcoidosis

Abstract: Our data indicate that both cigarette smoking and gender are important in shaping the clinical manifestations of sarcoidosis. The nature of the gender difference requires further study and may be related to differences in inflammatory response.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 25 publications
0
5
0
Order By: Relevance
“…Black Americans have a higher prevalence of extrathoracic involvement [30]. A recent study demonstrated that female smokers were more likely to have a reduced diffusion capacity for carbon monoxide than male smokers, and both female sex and smoking are associated with the development of extrapulmonary manifestations of the disease [64]. …”
Section: Differences In Prognosismentioning
confidence: 99%
“…Black Americans have a higher prevalence of extrathoracic involvement [30]. A recent study demonstrated that female smokers were more likely to have a reduced diffusion capacity for carbon monoxide than male smokers, and both female sex and smoking are associated with the development of extrapulmonary manifestations of the disease [64]. …”
Section: Differences In Prognosismentioning
confidence: 99%
“…8 In a US study of 518 patients, smokers also were found to have a higher incidence of extrapulmonary involvement, compared with that of nonsmokers. 21 Our study has several limitations. First, we cannot exclude the possibility that the observation is because of residual confounding.…”
Section: Discussionmentioning
confidence: 91%
“… 8 In a US study of 518 patients, smokers also were found to have a higher incidence of extrapulmonary involvement, compared with that of nonsmokers. 21 …”
Section: Discussionmentioning
confidence: 99%
“…Several previous studies suggest that smoking may be a protective factor against developing pulmonary sarcoidosis but may elevate the risk of extrapulmonary manifestations [ 23 , 24 ]. However, as is true of many presentations of sarcoidosis, geoepidemiological variations between populations are associated with diverse and varied manifestations.…”
Section: Discussionmentioning
confidence: 99%